Related references
Note: Only part of the references are listed.Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): evolutions in classification, etiopathogenesis, assessment and management
Alfred Mahr et al.
CURRENT OPINION IN RHEUMATOLOGY (2014)
Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg-Strauss syndrome)
Luc Mouthon et al.
JOURNAL OF AUTOIMMUNITY (2014)
Eosinophilic granulomatosis with polyangiitis (ChurgStrauss): state of the art
A. Vaglio et al.
ALLERGY (2013)
Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis
Alfred Mahr et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients
Frank Moosig et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
J. C. Jennette et al.
ARTHRITIS AND RHEUMATISM (2013)
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort
Cloe Comarmond et al.
ARTHRITIS AND RHEUMATISM (2013)
Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials
Maxime Samson et al.
JOURNAL OF AUTOIMMUNITY (2013)
Getting rid of MPO-ANCA: a matter of disease subtype
Jan P. Bremer et al.
RHEUMATOLOGY (2013)
Classification of antineutrophil cytoplasmic autoantibody vasculitides: The role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis
Sophia Lionaki et al.
ARTHRITIS AND RHEUMATISM (2012)
Defining disease activity and damage in patients with small-vessel vasculitis
P. A. MERKEL
CLEVELAND CLINIC JOURNAL OF MEDICINE (2012)
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes
Peter Valent et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
ANCA vasculitis: to lump or split?
Richard A. Watts et al.
RHEUMATOLOGY (2012)
The Five-Factor Score Revisited Assessment of Prognoses of Systemic Necrotizing Vasculitides Based on the French Vasculitis Study Group (FVSG) Cohort
Loic Guillevin et al.
MEDICINE (2011)
Churg-Strauss Syndrome: Clinical Symptoms, Complementary Investigations, Prognosis and Outcome, and Treatment
Bertrand Dunogue et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
The American College of Rheumatology 1990 criteria for the classification of churg-strauss syndrome (allergic granulomatosis and angiitis)
Alfonse T. Masi et al.
ARTHRITIS AND RHEUMATISM (2010)
Churg-Strauss syndrome: evidence for disease subtypes?
Christian Pagnoux et al.
CURRENT OPINION IN RHEUMATOLOGY (2010)
Practical approach to the patient with hypereosinophilia
Florence Roufosse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Effects of Duration of Glucocorticoid Therapy on Relapse Rate in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Meta-Analysis
Michael Walsh et al.
ARTHRITIS CARE & RESEARCH (2010)
Modification and validation of the Birmingham Vasculitis Activity Score (version 3)
C. Mukhtyar et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
EULAR recommendations for the management of primary small and medium vessel vasculitis
C. Mukhtyar et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Cardiac Involvement in Churg-Strauss Syndrome Impact of Endomyocarditis
Thomas Neumann et al.
MEDICINE (2009)
Assessment of damage in vasculitis: expert ratings of damage
Philip Seo et al.
RHEUMATOLOGY (2009)
Treatment of Churg-Strauss syndrome without poor-prognosis factors
Camillo Ribi et al.
ARTHRITIS AND RHEUMATISM (2008)
The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case crossover study
T. Hauser et al.
THORAX (2008)
Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction
M. P. Swanney et al.
THORAX (2008)
Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force
C. Mukhtyar et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Small-vessel and medium-vessel vasculitis
Philip Seo et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Churg-Strauss syndrome with poor-prognosis factors:: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients
Pascal Cohen et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Churg-Strauss syndrome
Christian Pagnoux et al.
CURRENT OPINION IN RHEUMATOLOGY (2007)
Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome
G Sablé-Fourtassou et al.
ANNALS OF INTERNAL MEDICINE (2005)
Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome
RA Sinico et al.
ARTHRITIS AND RHEUMATISM (2005)
Predicting mortality in systemic Wegener's granulomatosis: A survival analysis based on 93 patients
D Bligny et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
Churg-Strauss syndrome: Clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists
KA Keogh et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Churg-Strauss syndrome: clinical and serological features of 19 patients from a single Italian centre
A Della Rossa et al.
RHEUMATOLOGY (2002)
Churg-Strauss syndrome:: outcome and long-term follow-up of 32 patients
R Solans et al.
RHEUMATOLOGY (2001)
Share Paper
